LVTX - LAVA Therapeutics NV

QQQ $ 432.25 $ -0.90 (-0.21 %)

DIA $ 383.24 $ 0.05 (0.01 %)

SPY $ 510.00 $ -0.26 (-0.05 %)

TLT $ 88.82 $ 0.16 (0.18 %)

GLD $ 216.49 $ 0.44 (0.2 %)

Previous Close

$ 2.73

Open

$ 2.71

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 2.71 - $ 2.76

52 Week Range

$ 1.13 - $ 6.47

Volume

49,932

Average Volume

Market Cap

71.77M

Beta (5Y Monthly)

$ 0.61

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Reiterates Buy on LAVA...
03/21/2024 10:10:52

HC Wainwright & Co. analyst Arthur He reiterates LAVA Therapeutics (NASDAQ:LVTX) with a Buy and maintains $6 price target.

LAVA Therapeutics Q4 EPS $(0.24) Misses $(...
03/20/2024 11:13:41

LAVA Therapeutics (NASDAQ:LVTX) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of $...

LAVA Therapeutics shares are trading highe...
03/05/2024 12:50:37

LAVA Therapeutics Announces Pfizer Has Ach...
03/05/2024 12:31:51

LAVA Therapeutics N.V Filed U.S. Patent Ap...
02/29/2024 19:24:15

https://ppubs.uspto.gov/dirsearch-public/print/downloadPdf/20240067726

Watching LAVA Therapeutics N.V.; Shares Sp...
02/29/2024 18:29:35

Why Humana Shares Are Trading Lower By Ove...
01/25/2024 19:52:24

Shares of Humana Inc. (NYSE: HUM) fell sharply during Thursday’s session after the company reported fourth-quarter FY23 earning...

crude-oil-rises-2-tesla-shares-plunge-after-downbeat-results

Crude Oil Rises 2%; Tesla Shares Plunge Af...
01/25/2024 18:08:22

U.S. stocks traded slightly higher midway through trading, with the Nasdaq Composite gaining around 0.2% on Thursday. The Dow ...

dow-surges-over-100-points-us-gdp-growth-tops-estimates

Dow Surges Over 100 Points; US GDP Growth ...
01/25/2024 15:42:28

U.S. stocks traded higher this morning, with the Dow Jones index gaining over 100 points on Thursday. Following the market ope...

why-is-cancer-focused-lava-therapeutics-nano-cap-stock-trading-higher-today

Why Is Cancer Focused LAVA Therapeutics Na...
01/25/2024 15:11:21

LAVA Therapeutics collaborates with Merck on a clinical trial for anti-PD-1 therapy Keytruda in metastatic castration-resistant...

Market-Moving News for January 25th
01/25/2024 13:42:04

TSLA: -9% | Tesla shares are trading lower after the company reported worse-than-expected Q4 financial results. LVTX: 75% | LA...

LAVA Therapeutics Partners With Merck To E...
01/25/2024 12:10:18

Under the terms of the agreement, Merck will provide pembrolizumab for the dose escalation and expansion phases of LAVA's o...

HC Wainwright & Co. Reiterates Buy on LAVA...
11/17/2023 11:23:00

HC Wainwright & Co. analyst Arthur He reiterates LAVA Therapeutics (NASDAQ:LVTX) with a Buy and maintains $6 price target.

As Of September 30, 2023, Lava Therapeutic...
11/16/2023 12:10:37

LAVA Therapeutics Q3 EPS $(0.34) Down From...
11/16/2023 12:09:32

LAVA Therapeutics (NASDAQ:LVTX) reported quarterly losses of $(0.34) per share. This is a 950 percent decrease over earnings of...

What 5 Analyst Ratings Have To Say About L...
08/23/2023 15:00:29

JMP Securities Reiterates Market Outperfor...
08/23/2023 12:30:58

JMP Securities analyst Reni Benjamin reiterates LAVA Therapeutics (NASDAQ:LVTX) with a Market Outperform and maintains $6 pr...

HC Wainwright & Co. Maintains Buy on LAVA ...
08/23/2023 10:17:38

HC Wainwright & Co. analyst Arthur He maintains LAVA Therapeutics (NASDAQ:LVTX) with a Buy and lowers the price target f...

LAVA Therapeutics Q2 EPS $(0.48) Misses $(...
08/22/2023 11:17:47

LAVA Therapeutics (NASDAQ:LVTX) reported quarterly losses of $(0.48) per share which missed the analyst consensus estimate of $...

JMP Securities Reiterates Market Outperfor...
06/15/2023 12:25:17

JMP Securities analyst Reni Benjamin reiterates LAVA Therapeutics (NASDAQ:LVTX) with a Market Outperform and maintains $6 pr...